NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  EXACT SCIENCES CORP

EXACT SCIENCES CORP

exactsciences.com ↗
48
Latest disclosed NPS
26 Apr 2023
5
NPS entries
3 with a number
2021–23
Years covered
5 entries in all

In their words

“You've seen our Net Promoter Scores double from the low 20s in the first quarter of '21 to the low 40s this last quarter. Awareness of Cologuard as a brand is at an all-time high among consumers, relevant consumers and health care providers.”
— Kevin Conroy, Chairman and CEO, EXACT SCIENCES CORP · Earnings call, Q3 2022 · 3 Nov 2022
“And our Net Promoter Score has increased from 24 a year ago to 40 today. And that's among primary care physicians.”
— Kevin Conroy, Chairman and CEO, EXACT SCIENCES CORP · Earnings call, Q3 2021 · 2 Nov 2021
“These payouts reflected strong revenue performance and high patient and provider satisfaction, determined by Net Promoter Score. With 50% of the target bonus opportunity delivered to the CEO and CFO in the form of shares, the actual realized value of…”
— EXACT SCIENCES CORP · SEC proxy statement · filed 26 Apr 2023

Disclosed NPS over time

Every Net Promoter Score EXACT SCIENCES CORP has published, by date.

3040502022404048

NPS disclosures (5)

Search the database →

26 Apr 2023
NPS48

These payouts reflected strong revenue performance and high patient and provider satisfaction, determined by Net Promoter Score. With 50% of the target bonus opportunity delivered to the CEO and CFO in the form of shares, the actual realized value of…

— EXACT SCIENCES CORP · SEC proxy statement · filed 26 Apr 2023
SEC proxy statement ↗
3 Nov 2022
NPS40

You've seen our Net Promoter Scores double from the low 20s in the first quarter of '21 to the low 40s this last quarter. Awareness of Cologuard as a brand is at an all-time high among consumers, relevant consumers and health care providers.

— Kevin Conroy, Chairman and CEO, EXACT SCIENCES CORP · Earnings call, Q3 2022 · 3 Nov 2022
Earnings call, Q3 2022 ↗
29 Apr 2022
NPSProgram

…Hit all milestones ​ ​ 30% ​ ​ 21% ​ Enhance Customer Experience ​ ​ Patient and provider satisfaction determined by net promoter score (NPS) ​ ​ Improvement from 2020 baseline in overall NPS ​ ​ 10% ​ ​ 15% ​ Additional Metrics (1) ​ ​ Diversity ​ ​…

— EXACT SCIENCES CORP · SEC proxy statement · filed 29 Apr 2022
SEC proxy statement ↗
2 Nov 2021
NPS40

And our Net Promoter Score has increased from 24 a year ago to 40 today. And that's among primary care physicians.

— Kevin Conroy, Chairman and CEO, EXACT SCIENCES CORP · Earnings call, Q3 2021 · 2 Nov 2021
Earnings call, Q3 2021 ↗
29 Apr 2021
NPSProgram

Customer satisfaction goals were measured using target levels tied to net promoter scores determined using proprietary customer surveys. Our Compensation and Management Development Committee has determined that the disclosure of such target levels would…

— EXACT SCIENCES CORP · SEC proxy statement · filed 29 Apr 2021
SEC proxy statement ↗

Retention disclosures (0)

Open in the retention database →

No retention figures yet.

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.